Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Accessed Articles

C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors

Volume: 21   Issue: 1
Pp: 2-20
Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*
DOI: 10.2174/1568009620666201016121005

COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide promotion: free to download

Volume: 20   Issue: 6
Pp: 410-416
Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419

CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume: 20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220

Effects of Iron Chelation in Osteosarcoma

Volume: 21   Issue: 5
Pp: 443-455
Maura Argenziano, Alessandra Di Paola, Chiara Tortora, Daniela Di Pinto, Elvira Pota, Martina Di Martino, Silverio Perrotta, Francesca Rossi* and Francesca Punzo
DOI: 10.2174/1568009620666201230090531

The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future

Volume: 21   Issue: 5
Pp: 375-385
Zhaoyuan Xu, Guohua Ji, Ying Cui and Xiaobo Cui*
DOI: 10.2174/1568009621999210120193636

The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy

Volume: 21   Issue: 5
Pp: 401-415
Ana C. Henriques, Patrícia M. A. Silva, Bruno Sarmento and Hassan Bousbaa*
DOI: 10.2174/1568009621666210129095726

Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues

Volume: 21   Issue: 5
Pp: 428-442
Karthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser and Barbara Seliger*
DOI: 10.2174/1568009620666201207145019

PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance

Volume: 21   Issue: 4
Pp: 306-325
Sarah F. Giardina*, Elena Valdambrini, J. David Warren and Francis Barany
DOI: 10.2174/1568009621666210203110857

Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators open access plus

Volume: 21   Issue: 4
Pp: 353-359
Stefanie Rauscher, Richard Greil and Roland Geisberger*
DOI: 10.2174/1568009620666210108102723

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study

Volume: 20   Issue: 11
Pp: 887-895
Martina Catalano, Giandomenico Roviello*, Raffaele Conca, Alberto D’Angelo, Valeria Emma Palmieri, Benedetta Panella, Roberto Petrioli, Anna Ianza, Stefania Nobili, Enrico Mini and Monica Ramello
DOI: 10.2174/1568009620999200918122426

The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance

Volume: 21   Issue: 4
Pp: 326-352
Shaun Wood, Amber Willbanks and Jason X. Cheng*
DOI: 10.2174/1568009621666210127092828